Literature DB >> 19692105

Characterization of Chikungunya pseudotyped viruses: Identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein.

Beatriz Salvador1, Yanchen Zhou, Alain Michault, Marcus O Muench, Graham Simmons.   

Abstract

Chikungunya virus (CHIKV) is an alphavirus responsible for a number of large outbreaks. Here we describe the efficient incorporation of CHIKV envelope glycoproteins into lentiviral and rhabdoviral particles. Vectors pseudotyped with CHIKV envelope proteins efficiently transduced many cell types from different species. However, hematopoietic cell types were either partially or completely refractory. A mutation in E1 (A226V) has been linked with expansion of tropism for mosquito species, although differences in in vitro infection of mosquito cell lines have not been noted. However, pseudovirion infectivity assays detected subtle differences in infection of mosquito cells, suggesting an explanation for the changes in mosquito tropism. The presence of C-type lectins increased CHIKV pseudotyped vector infectivity, but not infection of refractory cells, suggesting that they act as attachment factors rather than primary receptors. CHIKV pseudotypes will serve as an important tool for the study of neutralizing antibodies and the analysis of envelope glycoprotein functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19692105      PMCID: PMC2760448          DOI: 10.1016/j.virol.2009.07.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  57 in total

1.  Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site.

Authors:  Afjal Hossain Khan; Kouichi Morita; Maria Del Carmen Parquet; Futoshi Hasebe; Edward G M Mathenge; Akira Igarashi
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

2.  Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry.

Authors:  Graham Simmons; Jacqueline D Reeves; Andrew J Rennekamp; Sean M Amberg; Andrew J Piefer; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-09       Impact factor: 11.205

3.  Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission.

Authors:  Li Wu; Thomas D Martin; Mary Carrington; Vineet N KewalRamani
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

4.  Experimental studies with chikungunya virus in Aedes aegypti and Aedes albopictus.

Authors:  K R Singh; K M Pavri
Journal:  Acta Virol       Date:  1967-11       Impact factor: 1.162

5.  Semliki forest virus entry and the endocytic pathway.

Authors:  M Marsh; M C Kielian; A Helenius
Journal:  Biochem Soc Trans       Date:  1984-12       Impact factor: 5.407

6.  Leukocytes and interferon in the host response to viral infections. II. Enhanced interferon response of leukocytes from immune animals.

Authors:  L A Glasgow
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

7.  Characterization of pseudotype VSV possessing HCV envelope proteins.

Authors:  Y Matsuura; H Tani; K Suzuki; T Kimura-Someya; R Suzuki; H Aizaki; K Ishii; K Moriishi; C S Robison; M A Whitt; T Miyamura
Journal:  Virology       Date:  2001-08-01       Impact factor: 3.616

8.  Chikungunya virus infection of cell monolayers by cell-to-cell and extracellular transmission.

Authors:  N Hahon; W D Zimmerman
Journal:  Appl Microbiol       Date:  1970-02

9.  In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes.

Authors:  Birke Bartosch; Jens Bukh; Jean-Christophe Meunier; Christelle Granier; Ronald E Engle; William C Blackwelder; Suzanne U Emerson; François-Loïc Cosset; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-14       Impact factor: 11.205

10.  DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells.

Authors:  Graham Simmons; Jacqueline D Reeves; Case C Grogan; Luk H Vandenberghe; Frédéric Baribaud; J Charles Whitbeck; Emily Burke; Michael J Buchmeier; Elizabeth J Soilleux; James L Riley; Robert W Doms; Paul Bates; Stefan Pöhlmann
Journal:  Virology       Date:  2003-01-05       Impact factor: 3.616

View more
  37 in total

1.  Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies.

Authors:  Edgar Davidson; Christopher Bryan; Rachel H Fong; Trevor Barnes; Jennifer M Pfaff; Manu Mabila; Joseph B Rucker; Benjamin J Doranz
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

3.  A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms.

Authors:  Yanchen Zhou; Kai Lu; Susanne Pfefferle; Stephanie Bertram; Ilona Glowacka; Christian Drosten; Stefan Pöhlmann; Graham Simmons
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

4.  Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.

Authors:  Rana Abdelnabi; Kristina Kovacikova; Johan Neyts; Leen Delang; Julia Moesslacher; Kim Donckers; Verena Battisti; Pieter Leyssen; Thierry Langer; Gerhard Puerstinger; Gilles Quérat; Changqing Li; Etienne Decroly; Ali Tas; Arnaud Marchand; Patrick Chaltin; Bruno Coutard; Martijn van Hemert
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 5.  Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.

Authors:  Laurie A Silva; Terence S Dermody
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

6.  Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Authors:  Rachel H Fong; Soma S R Banik; Kimberly Mattia; Trevor Barnes; David Tucker; Nathan Liss; Kai Lu; Suganya Selvarajah; Surabhi Srinivasan; Manu Mabila; Adam Miller; Marcus O Muench; Alain Michault; Joseph B Rucker; Cheryl Paes; Graham Simmons; Kristen M Kahle; Benjamin J Doranz
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

7.  Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells.

Authors:  Saliha Majdoul; Jeremie Cosette; Ababacar K Seye; Eric Bernard; Sophie Frin; Nathalie Holic; Nathalie Chazal; Laurence Briant; Lucile Espert; Anne Galy; David Fenard
Journal:  J Biol Chem       Date:  2017-09-19       Impact factor: 5.157

8.  Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism.

Authors:  Rana Abdelnabi; Daryl Staveness; Katherine E Near; Paul A Wender; Leen Delang; Johan Neyts; Pieter Leyssen
Journal:  Biochem Pharmacol       Date:  2016-09-21       Impact factor: 5.858

9.  Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane.

Authors:  Jing Jin; Jesús G Galaz-Montoya; Michael B Sherman; Stella Y Sun; Cynthia S Goldsmith; Eileen T O'Toole; Larry Ackerman; Lars-Anders Carlson; Scott C Weaver; Wah Chiu; Graham Simmons
Journal:  Cell Host Microbe       Date:  2018-08-23       Impact factor: 21.023

10.  Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.

Authors:  Natsuko Kishishita; Naokazu Takeda; Atchareeya Anuegoonpipat; Surapee Anantapreecha
Journal:  J Clin Microbiol       Date:  2013-02-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.